Downloadable

Real-World Use of Control-IQ Technology Infographic

Assessing Tandem t-slim X2 insulin pump with Control-IQ technology in the real-world outpatient setting over 12 months of use.

View Infographic

BROWSE TOPICS

Publication Date June 26, 2026

Content category

Guidelines & Research

Clinical focus

Type 1 Diabetes

Pediatrics

This resource is intended for educational purposes only for healthcare providers practicing in the United States. It does not constitute medical advice and is not a substitute for professional judgment or individualized patient care.

Evidence summaries for real-world care

Real-World Use of Control-IQ Technology Infographic

Download for easy reference, printing, or sharing with your care team.

References

Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-1603. doi:10.2337/dci19-0028
Graham R, Mueller L, Manning M, et al. Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study. Diabetes Technol Ther. 2024;26(1):24-32. doi:10.1089/dia.2023.0341